Cidara Therapeutics' Stock Extends Gains, Rockets 23% Premarket After Positive Drug Trial Results

MarketWatch.com - Real-time Headlines, MarketWatch: Real-time Headlines
Mon, 03/19/2018 - 3:53am

This is a Real-time headline. These are breaking news, delivered the minute it happens, delivered ticker-tape style. Visit www.marketwatch.com or the quote page for more information about this breaking news.

Topics: real-time delivered news breaking

Place your ad here
Loading...

BING NEWS:

Buy Rating Affirmed for Cidara Therapeutics Amid Promising Oncology Program Developments
Analyst Ed Arce of H.C. Wainwright maintained a Buy rating on Cidara Therapeutics (CDTX – Research ... progress in Cidara’s oncology Drug Fc-Conjugate (DFC) programs, particularly the ...
04/7/2024 - 9:45 pm | View Link
Cidara Therapeutics Stock (NASDAQ:CDTX), Quotes and News Summary
Palisade Bio transformed GI-focused pipeline through exclusive worldwide licensing agreement with Giiant Pharma, Inc. for multiple oral drug candidates targeting inflammatory bowel disease.
02/22/2024 - 9:38 am | View Link
Cidara Therapeutics Inc.
The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...
04/6/2023 - 6:43 am | View Link
Cidara Therapeutics, Inc. Common Stock (CDTX)
Stock prices may also move more quickly in this environment. Investors who anticipate trading during these times are strongly advised to use limit orders. Data is delayed at least 15 minutes.
11/8/2017 - 4:07 am | View Link
Cidara Therapeutics, Inc. Common Stock (CDTX)
Nasdaq Analyst Research provides analyst research for ratings consensus and a summary of stock price targets. Analysts evaluate the stock’s expected performance in a given time period based on ...
03/17/2015 - 9:18 am | View Link
More

More Movie News

More Business News

New health care teaching clinic opening in Oak Park
BizJournals, Monday - 04/22/2024 - 09:17 PM
This story is part of the Solving Sacramento journalism collaborative. Solving Sacramento is supported by funding from the James Irvine Foundation and James B. McClatchy Foundation. Our partners include California Groundbreakers, Capital Public Radio, Outword, Russian American Media, Sacramento Business Journal, Sacramento News & Review, Sacramento Observer and Univision 19. About six years ago, Dr.
More | Talk | Read It Later | Share
All about the coffee: David Lambert details plans for Ramblin' Joe's
BizJournals, Monday - 04/22/2024 - 09:15 PM
David Lambert's latest project is building a new prototype of their franchise cafe at Broad Avenue and Tillman Street.
More | Talk | Read It Later | Share
Former CHOP CEO and Spark co-founder to lead new biotech startup launched with $54M in funding
BizJournals, Monday - 04/22/2024 - 09:15 PM
Altschuler said the $54 million in funding "will put rocket boosters under Corner's pioneering work."
More | Talk | Read It Later | Share
Skyhawk’s latest biopharma collaboration is worth up to $1.8B
BizJournals, Monday - 04/22/2024 - 09:11 PM
Skyhawk has also previously unveiled partnerships with the likes of Vertex Pharmaceuticals Inc., Bristol Myers Squibb, Takeda Pharmaceuticals, Genentech and Biogen Inc.
More | Talk | Read It Later | Share
Scannell eyes new warehouse development in Saratoga County
BizJournals, Monday - 04/22/2024 - 08:51 PM
Scannell Properties of Indianapolis is seeking tenants for a new distribution site the developer plans to build off the Northway.
More | Talk | Read It Later | Share
New Mexicans to Know: Army veteran Nancy Parson brings passion for health care to Las Cruces
BizJournals, Monday - 04/22/2024 - 08:46 PM
An Army veteran with a passion for health care wants to make a lasting impact in the state her parents once called home.
More | Talk | Read It Later | Share

Cidara Therapeutics' Stock Extends Gains, Rockets 23% Premarket After Positive Drug Trial Results

Welcome to Wopular

MoviesWithButter : Our Sister Site

More Business News